|1.||Ley, Ludwin: 2 articles (01/2013 - 04/2012)|
|2.||Müller-Fielitz, Helge: 1 article (02/2014)|
|3.||Vogt, Florian M: 1 article (02/2014)|
|4.||Mildner, Martin: 1 article (02/2014)|
|5.||Barkhausen, Jörg: 1 article (02/2014)|
|6.||Raasch, Walter: 1 article (02/2014)|
|7.||Hübel, Nils: 1 article (02/2014)|
|8.||Marcovitz, Pamela A: 1 article (01/2013)|
|9.||Schumacher, Helmut: 1 article (01/2013)|
|10.||Billecke, Scott S: 1 article (01/2013)|
|1.||Hypertension (High Blood Pressure)
01/01/2011 - "A telmisartan-amlodipine combination has demonstrated significantly greater BP reductions compared with each monotherapy component in the overall population, and in particular in patients with moderate to severe hypertension and high-risk patients. "
01/01/2013 - "Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension."
09/01/2008 - "Evaluation of safety and efficacy of telmisartan-amlodipine combination in treating hypertension."
04/01/2012 - "This 8-week, randomized, double-blind, controlled study compared efficacy and tolerability of telmisartan/amlodipine (T/A) single-pill combination (SPC) vs the respective monotherapies in 858 patients with severe hypertension (systolic/diastolic blood pressure [SBP/DBP] ≥180/95 mm Hg). "
04/01/2012 - "Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study."
01/01/2013 - "The results of this post-hoc analysis further support the ability of the telmisartan/amlodipine combination to effectively reduce BP in hypertensive patients with obesity, diabetes, or metabolic syndrome, enabling the majority of patients to achieve target BP. This combination is also well tolerated, and may be considered a suitable option for these added-risk hypertensive patients."
|4.||Calcium Channels (Calcium Channel)
|5.||Angiotensin Receptors (Angiotensin II Receptor)